Shu‐Heng Jiang

3.4k total citations
75 papers, 2.1k citations indexed

About

Shu‐Heng Jiang is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Shu‐Heng Jiang has authored 75 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Molecular Biology, 26 papers in Cancer Research and 16 papers in Oncology. Recurrent topics in Shu‐Heng Jiang's work include Cancer, Hypoxia, and Metabolism (17 papers), RNA modifications and cancer (15 papers) and Cancer, Stress, Anesthesia, and Immune Response (9 papers). Shu‐Heng Jiang is often cited by papers focused on Cancer, Hypoxia, and Metabolism (17 papers), RNA modifications and cancer (15 papers) and Cancer, Stress, Anesthesia, and Immune Response (9 papers). Shu‐Heng Jiang collaborates with scholars based in China, Japan and Sweden. Shu‐Heng Jiang's co-authors include Zhigang Zhang, Li-Peng Hu, Xu Wang, Yahui Wang, Xiaomei Yang, Rongkun Li, Qin Yang, Jun Li, Ye Du and Jun Li and has published in prestigious journals such as Nature Communications, Gastroenterology and Cancer Research.

In The Last Decade

Shu‐Heng Jiang

73 papers receiving 2.1k citations

Peers

Countries citing papers authored by Shu‐Heng Jiang

Since Specialization

Citations

This map shows the geographic impact of Shu‐Heng Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shu‐Heng Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shu‐Heng Jiang more than expected).

Fields of papers citing papers by Shu‐Heng Jiang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shu‐Heng Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shu‐Heng Jiang. The network helps show where Shu‐Heng Jiang may publish in the future.

Co-authorship network of co-authors of Shu‐Heng Jiang

This figure shows the co-authorship network connecting the top 25 collaborators of Shu‐Heng Jiang. A scholar is included among the top collaborators of Shu‐Heng Jiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shu‐Heng Jiang. Shu‐Heng Jiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Pan-cancer analysis reveals multifaceted roles of nonmyelinating Schwann cells in gastrointestinal cancers 2025 ·Cancer Letters ·Hui Li, (unknown), (unknown), Xiaoping Miao, Shu‐Heng Jiang	2
2	Vitamin K‐dependent gamma‐carboxyglutamic acid protein 1 promotes pancreatic ductal adenocarcinoma progression through stabilizing oncoprotein KRAS and tyrosine kinase receptor EGFR 2025 ·Clinical and Translational Medicine ·(unknown), Qingsong Ye, Shan Zhang, (unknown), Xiaoqi Wang, Linli Yao, Lei Zhu, Shuyu Xiao, (unknown), Xueli Zhang, Shu‐Heng Jiang, Zhigang Zhang, (unknown), (unknown), Xiaomei Yang	3
3	AGFG1 increases cholesterol biosynthesis by disrupting intracellular cholesterol homeostasis to promote PDAC progression 2024 ·Cancer Letters ·(unknown), Minwei Yang, Jian Yang, Zheng Wu, (unknown), (unknown), (unknown), (unknown), (unknown), Jianyu Yang, Shu‐Heng Jiang, Lipeng Hu, Junfeng Zhang, Dejun Liu, Yan‐Miao Huo, Linli Yao, Yongwei Sun	4
4	Peripheral, central, and chemotherapy-induced neuropathic changes in pancreatic cancer 2024 ·Trends in Neurosciences ·(unknown), (unknown), Zhengyan Weng, Shan Zhang, Shu‐Heng Jiang	12
5	Reciprocal tumor‐platelet interaction through the EPHB1‐EFNB1 axis in the liver metastatic niche promotes metastatic tumor outgrowth in pancreatic ductal adenocarcinoma 2024 ·Cancer Communications ·Linli Yao, Wenxin Qin, (unknown), (unknown), Jian Yang, Qing Li, Hui Nie, (unknown), Xu Wang, Lei Zhu, (unknown), Yanli Zhang, Shu‐Heng Jiang, Zhigang Zhang, Xiaomei Yang, (unknown), Xueli Zhang	1
6	Nucleolar HEAT Repeat Containing 1 Up-regulated by the Mechanistic Target of Rapamycin Complex 1 Signaling Promotes Hepatocellular Carcinoma Growth by Dominating Ribosome Biogenesis and Proteome Homeostasis 2023 ·Gastroenterology ·Xiaomei Yang, Xiaoqi Wang, Li-Peng Hu, Mingxuan Feng, Yaoqi Zhou, Dongxue Li, Jun Li, (unknown), Yanli Zhang, Linli Yao, Hui Nie, Shan Huang, Qiang Xia, Xueli Zhang, Shu‐Heng Jiang, Zhigang Zhang	14
7	ACE2 negatively regulates the Warburg effect and suppresses hepatocellular carcinoma progression via reducing ROS-HIF1α activity 2023 ·International Journal of Biological Sciences ·Fangyuan Dong, Hui Li, Limin Liu, Linli Yao, Jiaofeng Wang, (unknown), Jianxia Ma, (unknown), Shan Zhang, Jun Li, Shu‐Heng Jiang, Xiaona Hu, Jie Chen, (unknown)	16
8	The SLITRK4-CNPY3 axis promotes liver metastasis of gastric cancer by enhancing the endocytosis and recycling of TrkB in tumour cells 2023 ·Cellular Oncology ·(unknown), (unknown), (unknown), Linli Yao, (unknown), Qing Li, Pei-Qi Huang, (unknown), Yangyang Wang, (unknown), Xiaoqi Wang, Xueli Zhang, Shu‐Heng Jiang, Shuang‐Qin Yi, Zhigang Zhang, Mingze Ma, Li-Peng Hu, Jia Xu, Jun Li	12
9	Reciprocal regulation of LOXL2 and HIF1α drives the Warburg effect to support pancreatic cancer aggressiveness 2021 ·Cell Death and Disease ·Rongkun Li, (unknown), Lili Zhu, Xiaoxin Zhang, Dejun Liu, Qing Li, Bo Ni, Li-Peng Hu, Zhigang Zhang, Yanli Zhang, Xu Wang, Shu‐Heng Jiang	27
10	Identification of a subset of immunosuppressive P2RX1-negative neutrophils in pancreatic cancer liver metastasis 2021 ·Nature Communications ·Xu Wang, Li-Peng Hu, Weiting Qin, Qin Yang, Deyu Chen, Qing Li, (unknown), Pei-Qi Huang, Chunjie Xu, Jun Li, Linli Yao, Yahui Wang, Guang-Ang Tian, Jian‐Yu Yang, Minwei Yang, Dejun Liu, Yongwei Sun, Shu‐Heng Jiang, Xueli Zhang, Zhigang Zhang	87
11	The physiology, pathology and potential therapeutic application of serotonylation 2021 ·Journal of Cell Science ·Shu‐Heng Jiang, Yahui Wang, Li-Peng Hu, Xu Wang, Jun Li, (unknown), Zhigang Zhang	20
12	Single-cell RNA sequencing reveals that targeting HSP90 suppresses PDAC progression by restraining mitochondrial bioenergetics 2021 ·Oncogenesis ·Li-Peng Hu, (unknown), Yan‐Miao Huo, Dejun Liu, Qing Li, Minwei Yang, Pei-Qi Huang, Chunjie Xu, Guang-Ang Tian, Linli Yao, Xueli Zhang, Yahui Wang, Jun Li, Zhigang Zhang, Shu‐Heng Jiang, Xin Xing, Xu Wang, Weiting Qin, Qin Yang	8
13	Nuclear-translocation of ACLY induced by obesity-related factors enhances pyrimidine metabolism through regulating histone acetylation in endometrial cancer 2021 ·Cancer Letters ·Miao Dai, (unknown), Jing Chen, Fei Liu, Yanjie Zhou, Yang Zhou, Qinyang Xu, Shu‐Heng Jiang, Shujie Zhao, Xinchun Li, Xuan Zhou, Qin Yang, Jun Li, Yahui Wang, Zhigang Zhang, Yincheng Teng	28
14	Inhibiting Importin 4-mediated nuclear import of CEBPD enhances chemosensitivity by repression of PRKDC-driven DNA damage repair in cervical cancer 2020 ·Oncogene ·Yang Zhou, Fei Liu, Qinyang Xu, (unknown), Xiao Li, Shu‐Heng Jiang, Li-Peng Hu, Xueli Zhang, Lili Zhu, Qing Li, Xiaolu Zhu, Hongfang Shao, Miao Dai, Yifei Shen, Bo Ni, Shuai Wang, Zhigang Zhang, Yincheng Teng	27
15	Neurotransmitters: emerging targets in cancer 2019 ·Oncogene ·Shu‐Heng Jiang, Li-Peng Hu, Xu Wang, Jun Li, Zhigang Zhang	162
16	Lysyl oxidase promotes liver metastasis of gastric cancer via facilitating the reciprocal interactions between tumor cells and cancer associated fibroblasts 2019 ·EBioMedicine ·Qing Li, Chunchao Zhu, Bo Ni, Zizhen Zhang, Shu‐Heng Jiang, Li-Peng Hu, Xu Wang, Xiao-Xin Zhang, Pei-Qi Huang, Qin Yang, Jun Li, Jianren Gu, Jia Xu, Kathy Qian Luo, Gang Zhao, Zhigang Zhang	76
17	Aberrant upregulation of KLK10 promotes metastasis via enhancement of EMT and FAK/SRC/ERK axis in PDAC 2018 ·Biochemical and Biophysical Research Communications ·Xiaoyan Cao, Xiao-Xin Zhang, Minwei Yang, Li-Peng Hu, Shu‐Heng Jiang, Guang-Ang Tian, Lili Zhu, Qing Li, Yongwei Sun, Zhigang Zhang	22
18	Overexpression of Rac GTPase Activating Protein 1 Contributes to Proliferation of Cancer Cells by Reducing Hippo Signaling to Promote Cytokinesis 2018 ·Gastroenterology ·Xiaomei Yang, Xiaoyan Cao, Ping He, Jun Li, Mingxuan Feng, Yanli Zhang, Xueli Zhang, Yahui Wang, Qin Yang, Lei Zhu, Hui Nie, Shu‐Heng Jiang, Guang-Ang Tian, Xiao-Xin Zhang, Qiang Liu, Jianguang Ji, Xuefeng Zhu, Qiang Xia, Zhigang Zhang	90
19	The histone demethylase KDM4D promotes hepatic fibrogenesis by modulating Toll-like receptor 4 signaling pathway 2018 ·EBioMedicine ·Fangyuan Dong, Shu‐Heng Jiang, Jun Li, Yahui Wang, Lili Zhu, Yiqin Huang, Xin Jiang, Xiaona Hu, Qi Zhou, Zhigang Zhang, (unknown)	31
20	Molecular analysis of gastric cancer identifies genomic markers of drug sensitivity in Asian gastric cancer 2018 ·Journal of Cancer ·Qin Yang, Chunchao Zhu, Yanli Zhang, Yangyang Wang, Yahui Wang, (unknown), Xiaomei Yang, Jun Li, Hui Nie, Shu‐Heng Jiang, Xiaoxin Zhang, (unknown), Qing Li, Xueli Zhang, Guang-Ang Tian, Li-Peng Hu, Lili Zhu, Gang Zhao, Zhigang Zhang	10

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact